Search

Author/Creator Reinisch, W

2. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon γ antibody, in patients with moderate to severe Crohn's disease. Issue 8 (21st February 2006)

Authors:
Reinisch, W; Hommes, D W; Van Assche, G; Colombel, J-F; Gendre, J-P; Oldenburg, B; Teml, A; Geboes, K; Ding, H; Zhang, L; Tang, M; Cheng, M; van Deventer, S J H; Rutgeerts, P; Pearce, T
Journal:
Gut
Issue:
Volume 55:Issue 8(2006)
Page Start:
1138
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A176 ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY. (7th March 2023)

Authors:
Pray, C; Narula, N; Wong, E C; Marshall, J K; Rangarajan, S; Islam, S; Bahonar, A; Alhabib, K F; Kontsevaya, A; Ariffin, F; Co, H U; Al Sharief, W; Szuba, A; Wielgosz, A; Diaz, M L; Yusuf, R; Kruger, L; Soman, B; Li, Y; Wang, C
Journal:
Journal of the Canadian Association of Gastroenterology
Issue:
Volume 6(2023)Supplement 1
Page Start:
20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A68 COST EFFECTIVENESS OF TIGHT CONTROL FOR CROHN'S DISEASE WITH ADALIMUMAB-BASED TREATMENT: ECONOMIC EVALUATION OF CALM TRIAL FROM CANADIAN PERSPECTIVE. (15th March 2019)

Authors:
Panaccione, R; Colombel, J; Bossuyt, P; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, A; Reinisch, W; Johnson, S; Buessing, M; Neimark, E; Petersson, J; Robinson, A M; Thakkar, R B; Lee, W; Skup, M; D'Haens, G
Journal:
Journal of the Canadian Association of Gastroenterology
Issue:
Volume 2(2019)Supplement 2
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. DOP040 Five-year colectomy data from the observational postmarketing ulcerative colitis study, a European registry for adults with ulcerative colitis treated with originator infliximab or conventional therapy. (16th January 2018)

Authors:
Panés, J; Lindsay, J O; Teich, N; Lindgren, S; Colombel, J -F; Cornillie, F; Ann Flynn, H; Huyck, S; Stryszak, P; Yao, R; Philip, G; Reinisch, W
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S058
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. DOP065 Long-term cost-effectiveness of tight control for Crohn's disease with adalimumab-based treatment: economic evaluation beyond 48 weeks of CALM trial. (16th January 2018)

Authors:
Panaccione, R; Colombel, J -F; Bossuyt, P; Baert, F; Vanasek, T; Danalioglu, A; Novacek, G; Armuzzi, A; Reinisch, W; Johnson, S; Buessing, M; Neimark, E; Petersson, J; Robinson, A M; Thakkar, R B; Lee, W -J; Skup, M; D'Haens, G
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S074
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗